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DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding 
densities in the brain of male rats fed a high-saturated-fat diet 
Abstract 
Low levels of docosahexaenoic acid (DHA) have been linked to a number of mental illnesses such as 
memory loss, depression and schizophrenia. While supplementation of DHA is beneficial in improving 
memory and cognition, the influence of dietary fats on the neurotransmitters and receptors involved in 
cognitive function is still not known. The aim of this study was to investigate serotonin receptor (5-HT1A 
and 5-HT2A), cannabinoid receptor (CB1) and gamma-aminobutyric acid type A (GABAA) receptor binding 
densities in the brain of male rats fed a high-saturated-fat (HF) diet, as well as the effect of DHA 
supplementation on HF diet. Alterations of these receptors in the post-mortem rat brain were detected by 
[3H]-WAY-100635, [3H]-ketanserin, [3H]-CP-55,940 and [3H]-muscimol binding autoradiography, 
respectively. In the hippocampus, the 5-HT1A, CB1 and GABAA receptor binding densities significantly 
increased in response to an HF diet, while in the hypothalamus, 5-HT1A and CB1 binding densities 
significantly increased in HF-fed rats. Importantly, DHA supplementation prevented the HF-induced 
increase of receptors binding density in the hippocampus and hypothalamus. Furthermore, DHA 
supplementation attenuated 5-HT2A receptor binding density in the caudate putamen, anterior cingulate 
cortex and medial mammillary nucleus, which was also increased in HF group. This study showed that an 
HF diet increased 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding densities in the brain regions involved 
in cognitive function and that dietary DHA can attenuate such alterations. These findings provide insight 
into the mechanism by which DHA supplementation ameliorates reduced cognitive function associated 
with an HF diet. 
Keywords 
fat, saturated, high, fed, rats, male, brain, densities, diet, binding, dha, receptor, gabaa, cb1, ht2a, ht1a, 5, 
prevents, altered 
Disciplines 
Medicine and Health Sciences 
Publication Details 
Yu, Y., Wu, Y., Patch, C., Wu, Z., Szabo, A., Li, D. & Huang, X. (2013). DHA prevents altered 5-HT1A, 5-HT2A, 
CB1 and GABAA receptor binding densities in the brain of male rats fed a high-saturated-fat diet. Journal 
of Nutritional Biochemistry, 24 (7), 1349-1358. 
Authors 
Yinghua Yu, Yizhen Wu, Craig Patch, Zhixiang Wu, Alexander Szabo, Duo Li, and Xu-Feng Huang 
This journal article is available at Research Online: https://ro.uow.edu.au/ihmri/319 
1 
 
Title: DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA 
 3 
receptor binding 1 
densities in the brain of male rats fed a high-saturated fat diet  2 
Authors: Yinghua Yu1,2, Yizhen Wu1, Craig Patch3, Zhixiang Wu1,4, Alexander Szabo1,5, Duo 4 
Li2, and Xu-Feng Huang
 6 
1 5 
Affiliations: 1. Illawarra Health and Medical Research Institute, School of Health Sciences, 7 
University of Wollongong, Wollongong, NSW 2522, Australia  8 
2. Department of Food Science and Nutrition, Zhejiang University, Zhejiang Province, China 9 
3. Clover Corporation Limited, Nu-Mega Ingredients Pty Ltd, NSW 2522, Australia; 10 
4. Department of Endocrinology and Metabolism, Affiliated Hospital of Liaoning University 11 
of Traditional Chinese Medicine, China 12 
5. ANSTO LifeSciences, Australian Nuclear Science and Technology Organisation, Sydney, 13 
NSW 2234, Australia 14 
 15 
*Corresponding author:  16 
 17 
Professor Xu-Feng Huang, MBBS, PhD 18 
School of Health Sciences,  19 
University of Wollongong, Northfields Avenue, 20 
NSW 2522, Australia 21 
 22 
Tel.: 61-02-42214300 23 
Fax: 61-02-42214096 24 
E-mail address: xhuang@uow.edu.au 25 
 26 
 27 
Abbreviated title: DHA prevents alterations of receptor binding  28 
 29 
 30 






Abstract  35 
Low levels of docosahexaenoic acid (DHA) have been linked to a number of mental illnesses 36 
such as memory loss, depression and schizophrenia. While supplementation of DHA is 37 
beneficial in improving memory and cognition, the influence of dietary fats on the 38 
neurotransmitters and receptors involved cognitive function is still not known. The aim of 39 
this study was to investigate serotonin receptor (5-HT1A and 5-HT2A
gamma-aminobutyric acid 
), cannabinoid receptor 40 
(CB1) and type A (GABAA) receptor binding densities in the brain 41 
of male rats fed a high-saturated fat (HF) diet, as well as the effect of DHA supplementation 42 
on HF diet. Alterations of these receptors in the post-mortem rat brain were detected by [3H]-43 
WAY-100635, [3H]-Ketanserin, [3H]-CP-55,940 and [3H]-Muscimol binding autoradiography, 44 
respectively. In the hippocampus, the 5-HT1A, CB1 and GABAA receptor binding densities 45 
significantly increased in response to a HF fat diet. While in the hypothalamus, 5-HT1A and 46 
CB1 binding densities significantly increased in HF fed rats. Importantly, DHA 47 
supplementation prevented the HF induced increase of receptors binding density in the 48 
hippocampus and hypothalamus. Furthermore, DHA supplementation attenuated 5-HT2A 49 
receptor binding density in the caudate-putamen, anterior cingulate cortex and medial 50 
mammillary nucleus, which was also increased in HF group. This study showed that a high-51 
saturated fat diet increased 5-HT1A, 5-HT2A, CB1 and GABAA
Keywords: DHA, high-saturated fat, serotonin receptor, CB1 receptor, GABA
 receptor binding densities in 52 
the brain regions involved in cognitive function, and that dietary DHA can attenuate such 53 
alterations. These findings provide insight into the mechanism by which DHA 54 
supplementation ameliorates reduced cognitive function associated with a high-saturated fat 55 
diet.  56 
A
58 
 receptor 57 
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Introduction  59 
Different types of dietary fats affect body metabolism and cognitive function differently [1]. 60 
Studies have shown that a diet high in saturated fat promotes fat deposition and impairs 61 
memory and learning, and even contributes to the development of depression [2-4]. 62 
Conversely, a diet high in n-3 polyunsaturated fat, especially docosahexaenoic acid (DHA), 63 
can have the opposite effect [2-4]. A growing body of clinical findings implicates low DHA 64 
status with being overweight [5], impaired cognitive function, and depression [6-8]. Plasma 65 
DHA was lowered in elderly subjects with depressive disorders compared to individuals 66 
without depression [8]. The tissue DHA content of the orbitofrontal cortex and cingulate 67 
cortex was also found to be lower in individuals with major depression [6, 7]. Beneficial 68 
effects of DHA by improving cognition and anti-depressive effects have been described in 69 
clinical trials and animal studies. There is evidence that DHA supplementation improves 70 
cognition [9], enhances memory [10] and induces an anti-stress response [11], however, the 71 
underlying mechanisms remain unclear. Certain brain areas such as the hippocampus and 72 
cingulated cortex are important for cognitive function. However, there is little information on 73 
how dietary fat influences key receptors in these brain regions, which are important in the 74 
regulation of cognitive and metabolic function.   75 
 76 
The neurotransmitter serotonin (5-HT) acts via 5-HT1A and 5-HT2A receptors and has an 77 
important role in various central functions including control of energy intake, obesity, 78 
memory and learning [12-14]. 5-HT1A receptors are distributed throughout the brain and are 79 
located either pre or post-synaptically, where they regulate various brain functions [12, 15]. 80 
As presynaptic autoreceptors, the 5-HT1A receptors are found in dorsal and median raphe 81 
nuclei and negatively regulate 5-HT synthesis. A highly palatable diet in rats increases the 82 
density of 5-HT1A pre-synaptic receptor in these regions, suggesting a decrease in synthesis 83 
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and consequently a decreased release of 5-HT [16]. 5-HT1A receptors as post-synaptic 84 
receptors have a wide distribution in the brain with high density in the cortical and limbic 85 
areas, especially in the hippocampus and cortex, and low expression in other brain regions 86 
such as the hypothalamus, striatum and amygdala [17]. Clinical studies have shown that 5-87 
HT1A receptor expression is negatively associated with memory function [18]. Postsynaptic 88 
5-HT2A receptors can be found in high levels in cerebral cortical areas and at intermediate 89 
levels in the hypothalamus, striatum and hippocampus [19, 20]. Using [125I] DOI binding 90 
autoradiography, a high-saturated fat diet increased 5-HT2A binding density in the 91 
ventromedial hypothalamic nucleus and anterior olfactory nucleus in diet induced obese mice, 92 
but not in mice resistant to obesity development [21]. Furthermore, using [3H]-Ketanserin 93 
autoradiography, 5-HT2A receptor binding densities were significantly increased in post-94 
mortem tissue from the temporal cortex of patients with dementia [22]. Based on the 95 
accumulated evidence of clinical trials, blockade of 5-HT2A receptor ameliorates both the 96 
positive and negative symptoms, and to some extent the cognitive deficits in schizophrenia 97 
[23, 24]. The highly selective 5-HT2A
 101 
 antagonists MDL 100907 and EMD 281014, both 98 
developed as anti-psychotics, have also been shown to enhance cognitive function in animal 99 
models [25, 26]. 100 
The cannabinoid CB1 receptor plays an important role in various aspects of neural functions 102 
including learning and memory, anxiety, depression, addiction, appetite and feeding 103 
behaviour. Both CB1 knockout mice and CB1 antagonist (SR141716)-treated wild-type mice 104 
exhibited deficits in extinction of spatial memory [27, 28]. The systemic administration of the 105 
CB1 agonist WIN55,212-2 in rats impaired the acquisition of contextual fear conditioning 106 
[29], which is known to depend on the hippocampus [30]. GABA is the major inhibitory 107 
neurotransmitter in the brain. There are two receptors that mediate GABA neurotransmission 108 
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in the brain; GABAA and GABAB. The inhibitory function of GABAA is increasingly being 109 
recognised as important in the regulation of cognition, emotion, memory and obesity. It has 110 
been reported that the density of GABAA receptors was increased in the cortex of 111 
schizophrenia patients in order to compensate for the lowered levels of GABA [31, 32]. 112 
Allelic variants in the GABAA
 117 
α6 receptor subunit gene (GABRA6) were also associated with 113 
abdominal obesity [33]. Furthermore, the majority of leptin's antiobesity effects were 114 
mediated by GABAergic neurons reducing inhibitory tone to postsynaptic anorexigenic 115 
POMC neurons in the hypothalamus [34]. 116 
The effect of a DHA supplemented high-saturated fat diet on these receptor binding densities 118 
in brain regions associated with cognition has not been thoroughly investigated. To address 119 
this issue, we have used multiple ligands including [3H]-WAY-100635, [3H]-Ketanserin, [3H]-120 
CP-55,940 and [3H]-Muscimol to examine the regional changes of 5-HT1A, 5-HT2A, CB1 and 121 
GABAA
 126 
 receptor in the rat brain. Rats were fed either high-saturated fat diet, DHA 122 
supplement in high-statured fat diet or low-fat diet for 4 weeks. We examined alterations in 123 
receptor expression in response to a high-saturated fat diet, and if these alterations could be 124 
prevented by a supplementation of dietary DHA.  125 
Experimental procedure  127 
Animals and dietary treatments 128 
Thirty male Wistar rats (300-320g) were obtained from the Animal Resources Centre (Perth, 129 
Western Australia, Australia) and housed in environmentally controlled conditions (22°C, 12 130 
hr light–dark cycle with light cycle from 06:00 to 18:00 h and dark cycle from 18:00 to 06:00 131 
h) with ad libitum access to standard laboratory chow and water. Rats were allowed 1 week to 132 
adapt to their new environment before experiments began. They were randomized into three 133 
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groups with different diets: (1) standard laboratory chow as the low-fat control (LF, fat 134 
content 10% in kcal, saturated fat 1%), (2) high-fat diet (HF, 25% in kcal, saturated fat 10%), 135 
(3) high-fat diet + 0.5% DHA. The dose of DHA supplementation used in this study was 136 
based on the dose recommended for humans at 250mg/70kg/day (European Food Safety 137 
Authority) [35]. After four weeks of dietary treatment, rats were sacrificed by rapid CO2 138 
asphyxiation between 07:00 and 09:00 hrs in order to minimize the impact of circadian 139 
variation, and the brains were immediately removed and frozen in liquid nitrogen. Five rats 140 
per group were used to examine [3H]-WAY-100635, [3H]-Ketanserin, [3H]-CP-55,940 and 141 
[3
 146 
H]-Muscimol binding in the brain. The study was approved by the University of 142 
Wollongong Animal Ethics Committee and all animal experiments were conducted in 143 
compliance with the National Health and Medical Research Council Australian, Code of 144 
Practice for the Care and Use of Animals for Scientific Purposes (2004). 145 
Histological procedures 147 
Coronal brain sections (14 μm) were cut in a cryostat at −18  °C from the level of Bregma -148 
0.24mm to -5.16mm [36], thaw-mounted onto poly-L-lysine coated microscope slides 149 
(Polysine™, Menzel GmbH & Co, KG) [37] and stored at -20 °C. 150 
 151 
[3H]-WAY-100635, [3H]-Ketanserin, [3H]-CP-55,940 and [3
[
H]-Muscimol binding 152 
autoradiography 153 
3H]-WAY-100635 autoradiography was performed to examine 5-HT1A receptor binding 154 
density following procedures as described in previous work from our laboratories [38]. Brain 155 
sections were warmed to room-temperature and pre-incubated in 50 nM Tris–HCl buffer (pH 156 
7.4) for 30 min. The sections were then incubated with 5 nM [3H]-WAY-100635 (specific 157 
activity 83.0 Ci/mmol, Amersham Biosciences, UK Limited) at room temperature for 2.5 hrs 158 
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in 50 mM Tris–HCl (pH 7.4) containing 10 μM pargyline (Sigma). Non-specific binding was 159 
determined by incubating consecutive sections exposed to 10 μM 5-HT. All sections were 160 
washed for 2 min and then 3 min in ice-cold 50 mM Tris–HCl buffer.  161 
 162 
[3H]-Ketanserin autoradiography was performed as described previously [19]. Binding of 163 
[3H]-Ketanserin (67.0Ci/mmol; PerkinElmer Life Sciences, Boston, MA, USA) to 5-HT2A 164 
receptors was measured by preincubating sections in 170 mM Tris-HCl buffer (pH 7.4) for 15 165 
min at room temperature. Sections were then incubated for 120 min at room temperature in 166 
buffer containing 2 nM [3
 170 
H]-Ketanserin. Nonspecific binding was determined by the addition 167 
of 2 μM spiperone to consecutive sections. Sections were washed in ice-cold buffer (2 × 10 168 
min), dipped in distilled water and dried. 169 
Binding of [3H]-CP-55,940 was used to assess binding density of CB1 receptor [39]. Sections 171 
were allowed to defrost and then preincubated for 30 min in Tris-HCl buffer (5% bovine 172 
serum albumin (BSA), 50 mM Tris-HCl, pH 7.4) at room temperature. The binding sites of 173 
CB1 receptor were defined by incubation with 10 nM [3
 180 
H]-CP-55,940. Nonspecific binding 174 
was determined in the presence of 10 μM CP-55,940. Following incubation for 2 hrs at room 175 
temperature, slides were washed firstly for 1 hr and then 3 hrs in ice-cold buffer (1% BSA, 50 176 
mM Tris–HCl, pH 7.4), and then finally washed for a further 5 min in buffer containing no 177 
BSA. Slides were then dipped briefly in ice-cold distilled water and dried under a gentle 178 
stream of cool air.  179 
[3H]-Muscimol binding was performed to examine GABAA receptor binding density based 181 
on the method described in previous work from our laboratories [31]. Briefly, all sections 182 
underwent three 5 min pre-incubations at 4 °C in 50 mM Tris-citrate (pH 7.0). Sections were 183 
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then incubated for 45 min at 4 °C in the same buffer containing 3 nM [3H]-Muscimol 184 
(specific activity 29.5 Ci/mmol, PerkinElmer, USA). Non-specific binding was determined 185 
by incubating adjacent sections in [3
 188 
H]-Muscimol plus 100 μM GABA. Following incubation, 186 
sections were rinsed four times for 2s each in 4 °C buffer. 187 
Quantification and statistical analysis 189 
Quantification of binding sites was performed on a high-resolution Beta Imager (BioSpace, 190 
Paris, France) according to our previous study [40]. Briefly, sections were placed in a sample 191 
holder inside the detection chamber of the Beta Imager. The levels of bound radioactivity in 192 
the brain sections were directly determined by counting the number of β-particles emerging 193 
from the tissue sections. The Beta Vision Plus program (BioSpace, France) was used to 194 
measure the activities in the regions of interest. Radioligand binding signal was expressed in 195 
counts per minute per square millimetre (cpm/mm2), and with the use of standards was 196 
converted to fmol/mg tissue equivalents. The receptor density in various brain regions was 197 
quantified by measuring the average density of each region in three to five adjacent brain 198 
sections. Different brain regions were identified by reference to a standard rat brain atlas [36]. 199 
Data was expressed as mean ± SEM. [3H]-WAY-100635, [3H]-Ketanserin, [3H]-CP-55,940 200 
and [3
 205 
H]-Muscimol binding densities for each brain region were analyzed using a one-way 201 
ANOVA followed by a post-hoc Tukey–Kramer–HSD test using the SPSS 15.0 program 202 
(Chicago, IL). P values of less than 0.05 were regarded as statistically significant, and P 203 




 receptor binding  207 
1A receptor was widely distributed throughout the rat brain (Table 1). High 5-HT1A 208 
9 
 
receptor density was observed in the hippocampus, anterior cingulated cortex (ACC), lateral 209 
septal nucleus, primary motor cortex, and medial posterodorsal amygdala. Binding to 5-HT1A
Within the hippocampus there was a significant effect of dietary intervention on 5-HT
 210 
receptor was also observed in the ventromedial hypothalamus (VMH) and piriform cortex in 211 
lower levels. 212 
1A 213 
receptor density (F(2, 12)=11.641, P =0.002) (Table 1). The rats on HF diet had significantly 214 
higher 5-HT1A binding density (+54%, P =0.006), compared to rats on LF diet. For the DHA 215 
supplemented group, 5-HT1A binding density was significantly lower than the HF group (-216 
40%, P =0.002), but there was no significant difference in 5-HT1A
A dietary effect was also observed on 5-HT
 binding density in the 217 
hippocampus between DHA group and LF group (Fig 1A, Fig 2). 218 
1A receptor density within the VMH (F(2, 219 
12)=8.222, P =0.006) (Table 1). Rats maintained on HF diet had significantly higher 5-HT1A 220 
receptor expression in VMH than rats on LF diet (+58%, P =0.007). In addition, dietary 221 
intervention by the addition of DHA to the HF diet significantly decreased receptor densities 222 
compared to the rats on HF diet (-31% decrease, P =0.022), but there was no significant 223 
difference in 5-HT1A
5-HT2A binding density 226 
 receptor expression in the VMH between the DHA and LF group (Fig 224 
3A, Fig 2). 225 
There was abundant binding of [3H]-Ketanserin to 5-HT2A receptors in the ACC, caudate 227 
putamen, medial mammillary nucleus (MM), primary motor cortex, piriform cortex, medial 228 
posterodorsal amygdala and VMH. 5-HT2A
5-HT
 receptor expression was also observed at lower 229 
levels in the hippocampus (Table 2). 230 
2A binding density in the ACC differed between the various diet treatment groups in this 231 
study (F(2, 12)=12.474, P =0.001) (Table 2). The 5-HT2A binding density was significantly 232 
higher in the HF group than the LF or HF + 0.5% DHA group (+71%, P =0.003 and +75%, P 233 
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=0.002 respectively) (Fig 4A and Fig 5). There was no significant difference between DHA 234 
and LF group. 235 
Within the caudate putamen dietary intervention had a significant effect on 5-HT2A binding 236 
density (F(2, 12)=11.179, P =0.002) (Table 2). Rats fed the HF diet had significantly higher 5-237 
HT2A binding density (+43%, P =0.001) compared to rats on the LF diet. The DHA 238 
supplemented group had significantly lower 5-HT2A
This study also demonstrated differences between diet treatment groups in 5-HT
 binding density compared with the HF 239 
group (-19% lower, P =0.026), while there was no significant difference between DHA group 240 
and LF group (Fig 4B and Fig 5). 241 
2A receptor 242 
density in the MM (F(2, 12)=6.857, P =0.010) (Table 2). In the HF group 5-HT2A
CB1 receptor binding density 248 
 binding 243 
density was 47% higher than the LF group (P =0.026) and 55% higher than the DHA 244 
supplemented group (P =0.015). No difference was observed between LF and DHA groups 245 
(Fig 4C and Fig 6). A similar pattern of receptor expression in response to diet treatment was 246 
also observed in the anterior amygdaloid area. 247 
Diet affected the expression of CB1 receptor within the hippocampus (F(2, 12)
There was also a significant effect by dietary intervention on CB1 receptor density in the Arc 254 
(F
=2.960, P 249 
=0.048) (Table 3). The rats on HF diet had 43% elevated CB1 receptor density compared with 250 
rats on LF diet (P =0.007) (Fig 1B, Fig 7). DHA supplemention significantly lowered CB1 251 
receptor binding density compared with the HF group (-22%, P =0.041), but there was no 252 
significant difference in hippocampal CB1 receptor density between the DHA and LF groups. 253 
(2, 12)=37.138, P <0.001) (Table 3). In this region, rats on the HF diet had significantly 255 
higher CB1 receptor density than the rats on LF diet (+64%, P <0.001) (Fig 3B, Fig 7). The 256 
supplementation of DHA in the HF diet significantly decreased receptor expression compared 257 
to the rats on HF diet (-39%, P <0.001), but no difference was observed between DHA and 258 
11 
 
LF groups. 259 
Furthermore, HF diet significantly increased CB1 receptor density in the substantia nigra 260 
(SN), ventral tegmental area (VTA), and amygdala compared with LF diet (SN: +37%, P 261 
=0.003; VTA: +15%, P =0.020; amygdala: +20%, P =0.045) (Table 3). CB1 receptor binding 262 
density was decreased with DHA supplementation compared with the HF group in these brain 263 
areas. There was no effect of dietary intervention on CB1 in the VMH, caudate putamen, 264 
piriform cortex, primary motor cortex and ACC. 265 
GABAA
GABA
 binding density 266 
A receptor binding density in the hippocampus was affected by the different diets 267 
utilised in this study (F(2, 12)=4.386, P =0.040) (Table 4). Hippocampal GABAA receptor 268 
density was increased 53% in the HF group compared to the LF group (P =0.021) (Fig 1C, 269 
Fig 8), while DHA supplementation significant lowered the HF induced elevation in GABAA 270 
receptor binding density by 42% (P =0.038). There was also a positive correlation between 271 
CB1 and GABAA
In the thalamus and posterior cingulated cortex (PCC), HF diet significantly decreased 273 
GABA
 receptor binding density in the hippocampus (R=0.593, P =0.025) (Fig 9). 272 
A receptor density compared with LF diet (thalamus, -41%, P =0.020; PCC -60%, P 274 
=0.011) (Table 4). While GABAA receptor density was significantly increased by DHA 275 
supplementation compared with HF group in these brain areas (thalamus, +77%, P =0.011; 276 
+PCC 154%, P =0.009). There was no significant effect of dietary intervention on GABAA
Energy intake, body weight, and plasma leptin level of rats with dietary intervention 279 
 277 
receptor density in the ACC. 278 
The average of energy intake during the dietary treatment was significantly different among 280 
the three groups (P =0.010, HF: 94.38±2.69 kcal/24hours; LF: 84.69±1.56 kcal/24hours; HF 281 
+ 0.5% DHA: 90.81±1.86 kcal/24hours), in which HF group was significantly higher than LF 282 
group (P =0.007). No significant difference was found between other groups. The four week 283 
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accumulative energy intake was also significantly higher in HF group than the LF group 284 
(11.44%, P = 0.012). There was no significant difference in body weight changes among 285 
three groups (P =0.503, HF: 84.80±5.48g; LF: 81.78±6.05g; HF + 0.5% DHA: 83.00±6.04g). 286 
The plasma level of leptin in HF diet fed rats (11.47±2.17ng/ml) was significantly higher than 287 
that of the LF group (4.72±0.73ng/ml) (P =0.005). DHA supplementation decreased the 288 
plasma leptin level (7.21±1.01ng/ml) of rats compared with HF group in statistically 289 
significant trend (P =0.070), while there was no significant difference in plasma leptin 290 




Serotonin, cannabinoids and GABA systems play an important role in cognitive function [14, 295 
29, 31], and a chronic high-saturated fat diet has been shown to affect memory and learning 296 
[2]. Therefore, the effects of high-saturated fat diets on these neurotransmitter systems are of 297 
interest. This study showed that a high-saturated fat diet increased the density of 5-HT1A 298 
receptor in the hippocampus and VMH, 5-HT2A receptor in the ACC, caudate putamen and 299 
MM, CB1 receptor in the hippocampus, Arc, SN, VTA and amygdale, and GABAA
 304 
 receptor 300 
in the hippocampus. These regions are primarily limbic structures associated with the 301 
regulation of cognition. In addition, these HF diet induced changes in receptor density can be 302 
prevented by dietary supplementation of 0.5% DHA. 303 
A number of changes in receptor expression have been observed in the brain of individuals 305 
with abnormal cognitive function. It has been reported that 5-HT1A receptor binding density 306 
in the human hippocampus is negatively correlated with memory [18]. Furthermore, 5-HT1A 307 
and 5-HT2A receptor binding densities are significantly increased in the temporal cortex of 308 
13 
 
patients with dementia [22]. Both GABAA and CB1 receptor densities are increased in the 309 
posterior cingulated cortex of schizophrenia [41, 42]. This study similarly found alterations in 310 
receptor density in response to a high-saturated fat diet, specifically increased 5-HT1A, 5-311 
HT2A, GABAA
 320 
 and CB1 receptor densities in a number of brain regions, particularly in the 312 
limbic structures. Although the mechanism for the alteration of receptor binding densities is 313 
unclear, such effects could be due to the high-saturated fat diet decreasing the level of the 314 
respective neurotransmitters in the limbic regions. This is supported by a study showing that 315 
a high-fat diet (20% corn oil) for six weeks significantly decreased 5-HT levels in the 316 
brainstem of rats [43]. In addition, maternal high-fat consumption results in a significant 317 
decrease in CSF 5-HT content leading to 55% of offspring with increased anxiety as assessed 318 
by the novel object tests, and 78% with aberrant behavior (anxious and/or aggressive) [44].  319 
We found that hippocampal 5-HT1A binding density was increased in rats fed a high-saturated 321 
fat diet. Hippocampal circuits play an important role in learning and memory, but also in the 322 
hedonic aspects of eating [18, 45]. 5-HT1A receptors in the hippocampus are negatively 323 
associated with memory function in clinical and animal studies [18, 46]. Using positron 324 
emission tomography (PET), a significant negative correlation was found between explicit 325 
memory function and 5-HT1A receptor expression localized in the bilateral hippocampus of 326 
healthy subjects. Furthermore, administration of the 5-HT1A agonist tandospirone dose-327 
dependently impaired explicit verbal memory [18]. In a rat study, injection of the 5-HT1A 328 
agonist 8-OH-DPAT into hippocampus resulted in memory and learning impairment [46]. 329 
Conversely, administration of WAY 100635, a 5-HT1A antagonist, into the hippocampus of 330 
rats prevented the deficit of spatial learning induced by administration of CPP, a NMDA 331 
receptor antagonist [47]. Recent findings indicate that dietary factors which promote 332 
excessive food intake and weight gain can also interfere with hippocampal functioning. For 333 
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example, epidemiological and animal studies show that intake of diets high in saturated fat 334 
are associated with memory deficits and microglial activation (indicating inflammation 335 
and/or gliosis) in the hippocampus [2, 3]. Therefore, the high-saturated fat diet induced 336 
increase in hippocampal 5-HT1A
 340 
 receptor expression observed in this study may be involved 337 
in impairment of hippocampus function associated with learning and memory which in turn 338 
contributes to an increased energy intake.  339 
Furthermore, we found that both CB1 and GABAA receptor density were increased in the 341 
hippocampus of rats fed high-saturated fat diet. It is known that CB1 receptors are highly 342 
expressed in the hippocampus and are involved in memory function in this brain region. An 343 
intrahippocampal administration of rimonabant, a CB1 antagonist, completely attenuated the 344 
memory disruptive effects of cannabinoid induced memory impairment [48]. Systemic and 345 
intrahippocampal administration of cannabinoid agonists have been shown to impair 346 
hippocampal-dependent memory tasks [48, 49]. Oral administration of a CB1 inverse agonist, 347 
SLV319, inhibits the CB1 receptor-mediated catalepsy induced by HU-210 ip injection in 348 
mice [50]. In the present study, the elevated CB1 receptor binding density suggests that 349 
activation of CB1 in the hippocampus may contribute to high-saturated fat associated 350 
memory deficits. Endocannabinoid (eCB) ligands have been shown to act on the CB1 351 
receptor to inhibit the release of GABA in the rat hippocampus [51]. In this study the 352 
increased GABAA receptor expression in response to high-fat diet may reflect decreased 353 
GABA as a consequence of CB1 receptor activation in the hippocampus. This is supported by 354 
our observation that CB1 receptor density is positively correlated with GABAA receptor 355 
density. Furthermore, a previous study showed that in high-fat diet induced obese mice CB1 356 
receptor immunoreactivity and the eCBs, anandamide and 2-arachidonoyl glycerol (2-AG) 357 
were increased in the hippocampus [52]. In this study CB1 receptor binding density in the 358 
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hippocampus was increased even without any changes in body weight. This suggests that 359 
high-fat diet alone rather than obesity increases CB1 binding.  360 
 361 
Both clinical trials and animal studies have shown that DHA supplementation can improve 362 
learning and memory [53, 54]. Conversely, depletion of DHA in rat brain was found to 363 
increase 5-HT1A expression in the hippocampus and was associated with impairment of 364 
spatial learning and memory [55, 56]. In our study, addition of DHA to the diet prevented the 365 
increase of hippocampal 5-HT1A density in rats induced by a high-saturated-fat diet. DHA 366 
supplementation is also able to prevent increased CB1 and GABAA receptor densities 367 
induced by high-fat diet, as shown in this study. These findings suggest the effect of DHA 368 
supplementation on improving learning and memory may be via its influence on hippocampal 369 
5-HT1A, CB1 and GABAA
 371 
 systems. 370 
The hypothalamus is well recognised as a critical centre in the regulation of energy balance. 372 
Hypothalamic 5-HT1A receptors are involved in the control of negative energy balance. A 373 
negative relationship has been reported between the 5-HT content in the hypothalamus and 374 
amount of fat and food intake in rodents. For example, an infusion of 5-HT into the 375 
hypothalamus can lead to a dose-related decrease in the amount of fat intake in either fat- or 376 
carbohydrate- preferring rats [57]. The intrahypothalamic injection of a 5-HT1A agonist, 8-377 
OH-DPAT, decreases food intake and promotes satiety [58]. Conversely, intra-hypothalamic 378 
injection of WAY-100635, a 5-HT1A antagonist, blocks the anorexic effect induced by 5-HT 379 
[59]. The present study showed that rats fed a high-fat diet had increased 5-HT1A receptor 380 
expression in the ventromedial hypothalamus (VMH). This finding supports the assertion that 381 
a high-fat diet significantly decreases central 5-HT levels in rats [43]. Moreover, in the 382 
present study DHA supplementation prevented the increase in VMH 5-HT1A receptor density 383 
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induced by a high-saturated fat diet, which is in agreement with various reports in the 384 
literature. Previous studies have shown that n-3 PUFA/DHA intake influences 5-HT levels in 385 
the brain. A positive association has been reported between the amount of dietary DHA and 386 
brain 5-HT in piglets [60]. While rats maintained on a n-3 deficient diet have a low response 387 
to fenfluramine induced 5-HT stimulation [61]. Finally, n-3 PUFA supplementation in mice 388 
reverses the stress-induced reduction in 5-HT levels [62]. 389 
 390 
CB1 receptor expression was also increased in the Arc of the hypothalamus as a result of 4 391 
weeks of high-saturated fat diet, and this was prevented by dietary DHA supplementation. 392 
Hypothalamic eCBs and the CB1 receptor are involved in food intake and the response to 393 
peripheral feeding signals. Intravenous injection of leptin reduces the levels of the eCBs 394 
anandamide and 2-AG in the hypothalamus of normal rats and ob/ob mice [63]. High-395 
saturated fat diets increase plasma leptin thereby downregulating eCBs in the Arc, which may 396 
have led to the upregulation of Arc CB1 receptor density observed in this study. Moreover, 397 
the prevention of hyperleptinemia in high-saturated fat fed rats supplemented with DHA may 398 
have played a role in maintaining CB1 receptor binding density at levels similar to LF rats.  399 
 400 
In the present study a high-saturated fat diet increased 5-HT2A receptor binding density in the 401 
caudate putamen (striatum), ACC and MM of rats. The striatal serotonergic (5-HT) system is 402 
involved in reward behaviour; elevated 5-HT neurotransmission increases reward (positive 403 
feedback) sensitivity and decreases negative feedback sensitivity in rats [64, 65]. Rats fed a 404 
high-saturated fat diet have lowered levels of 5-HT release from striatal slices compared to 405 
rats fed a low-fat diet [64]. High saturated-fat diet induced obesity has been considered as a 406 
compulsive disorder reflecting a “reward deficiency syndrome” [66]. Therefore, the increase 407 
in striatal 5-HT2A receptor binding density observed in this study may contribute to deficits in 408 
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the reward system. The ACC and MM are involved in cognitive and memory function [67, 409 
68]. Studies with functional neuroimaging techniques, including PET and functional 410 
magnetic resonance imaging (fMRI), have ascribed the ACC with cognitive function and 411 
working memory [69]. Rodents with lesions of the MM are impaired on tests of spatial 412 
memory tasks and working memory [70, 71]. When rats are fed a high-fat diet they show a 413 
reduction in their cognitive ability and a decline in working memory after just nine days [72]. 414 
The 5-HT2A receptor plays an important role in cognitive abilities and working memory 415 
process [13, 73]. In the present study, 5-HT2A
 418 
 receptor binding density increased in brain 416 
regions related to cognition and memory (ACC and MM). 417 
Decreased DHA content in the brain is associated with increased density of cortical 5-HT2A 419 
receptors and altered serotonergic neurotransmission [74, 75]. Perinatal DHA-deficient rats 420 
have significantly lowered 5-HT content in the prefrontal cortex [74]. Moreover, a n-3 421 
PUFA-supplemented diet reverses decreased brain 5-HT levels in mice subjected to chronic 422 
mild stress [76]. In the present study adding DHA into the high-saturated fat diet of rats 423 
prevents increased levels of 5-HT2A binding density in the striatum, ACC and MM. The 424 
previously discussed ability of DHA supplementation to maintain central 5-HT levels is a 425 
potential mechanism by which DHA prevents 5-HT2A receptor upregulation. In addition, 426 
DHA content influences the physicochemical properties of neuronal membranes, and thus 427 
modulates the function of membrane bound proteins, such as receptors [77, 78]. Alterations 428 
in the fatty acid composition of neural membranes with DHA supplementation may result in 429 
changes in the affinity of neuronal receptors towards their neurotransmitter [77]. Therefore it 430 
is also possible that DHA directly affects the 5-HT2A receptor by increasing affinity to its 431 
neurotransmitter, negating the need for an increase in expression to cope with reduced 5-HT 432 
levels. DHA can affect gene expression as well as mRNA stability [77]. It is therefore also 433 
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possible that DHA exerts its effects on the 5-HT2A
 437 
 receptor at a transcriptional level. 434 
However, the exact mechanism by which DHA influences this receptor requires further 435 
research.  436 
In summary, we found that a high-saturated fat diet significantly increased 5-HT1A, CB1 and 438 
GABAA receptor binding densities in various rat brain regions, especially in limbic structures 439 
such as hippocampus and hypothalamus, which are important in the regulation of energy 440 
balance, learning, memory and cognitive functions. Furthermore, 5-HT2A
 454 
 receptor binding 441 
was increased in the caudate putamen, anterior cingulated cortex and medial mammillary 442 
nucleus of rats fed a high-saturated fat diet. The anatomical distributions of these receptor 443 
alterations suggest serotonin, cannabinoid and GABA receptor contribute at least partially to 444 
cognitive dysfunctions and abnormal energy balance induced by high-saturated fat diet, 445 
which is well supported by current literature. Importantly, the addition of dietary DHA 446 
prevented alteration of these receptor binding densities in rats induced by high-fat diet. The 447 
present findings point to DHA acting on numerous receptor systems in various areas of the 448 
brain. Furthermore, our results support the assertion that DHA supplements have beneficial 449 
effects on improving memory and cognition. Therefore, potential strategies to improve 450 
mental function against the adverse effects of high-saturated fat diets include targeting the 451 
serotonin, CB1 and GABA receptor systems, as well the proper application of molecular 452 
nutrition using supplements such as DHA. 453 
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Figure Legends: 673 
 674 
Fig 1. The effect of dietary intervention on [3H]-WAY-100635 (A), [3H]-CP55940 (B) and 675 
[3
 679 
H]-Muscimol (C) binding (nCi/mg tissue) in the hippocampus of the rat brain. Data are 676 
expressed as mean ± SEM. Abbreviations: LF, low-fat diet; HF, high-saturated fat diet; DHA, 677 
n-3 polyunsaturated docosahexaenoic acid; Hip: hippocampus. *P <0.05 vs. HF.  678 
Fig 2. Autoradiograph depicting [3H]-WAY-100635 binding in the hippocampus and 680 
ventromedial hypothalamus (VMH) of rats fed a LF (B), HF (C) and HF+DHA diet (D). 681 
Panel A is from a rat brain atlas. The density of [3H]-WAY-100635 binding was significantly 682 
increased in the hippocampus and VMH by HF diet, whereas the DHA supplement prevented 683 
the increase of [3
 686 
H]-WAY-100635 binding by HF diet. LF, low-fat diet; HF, high-saturated 684 
fat diet; DHA, n-3 polyunsaturated docosahexaenoic acid. 685 
Fig 3. The effect of dietary intervention on [3H]-WAY-100635 (A) and [3
Fig 4. The effect of dietary intervention on [
H]-CP55940 (B) 687 
binding (nCi/mg tissue) in the hypothalamus of the rat brain. Data are expressed as mean ± 688 
SEM. Abbreviations: LF, low-fat diet; HF, high-saturated fat diet; DHA, n-3 polyunsaturated 689 
docosahexaenoic acid; VMH, ventromedial hypothalamus; Arc, hypothalamic arcuate 690 
nucleus. *P <0.05 vs. HF.  691 
3
 696 
H]-Ketanserin binding density (nCi/mg tissue) 692 
in the rat brain. Data are expressed as mean ± SEM. Abbreviations: MM, medial mammillary 693 
nucleus; CPu, caudate putamen; ACC, anterior cingulate cortex; LF, low-fat diet; HF, high-694 
saturated fat diet; DHA, n-3 polyunsaturated docosahexaenoic acid. *P <0.05 vs. HF.  695 
Fig 5. Autoradiograph depicting [3H]-Ketanserin binding in the anterior cingulae cortex and 697 
caudate putamen of rats on LF (B), HF (C) and HF+DHA diet (D). Panel (A) is from a rat 698 
26 
 
brain atlas. The density of [3H]-Ketanserin binding was significantly increased in the anterior 699 
cingulae cortex and caudate putamen by HF diet whereas the DHA supplement prevented the 700 
increase of [3
 703 
H]-Ketanserin binding by HF diet. LF, low-fat diet; HF, high-saturated fat diet; 701 
DHA, n-3 polyunsaturated docosahexaenoic acid. 702 
Fig 6. Autoradiograph depicting [3H]-Ketanserin binding in the medial mammillary nucleus 704 
of rats on LF (B), HF (C) and HF+DHA diet (D). Panel (A) is from a rat brain atlas. The 705 
density of [3H]-Ketanserin binding was significantly increased in the medial mammillary 706 
nucleus induced by HF diet, whereas the DHA supplement prevented the increase of [3
 710 
H]-707 
Ketanserin binding by HF diet. LF, low-fat diet; HF, high-saturated fat diet; DHA, n-3 708 
polyunsaturated docosahexaenoic acid. 709 
Fig 7. Autoradiograph depicting [3H]-CP-55,940 binding in the hippocampus (A-C) and 711 
hypothalamic arcuate nucleus (D-F) of rats on LF (A and D), HF (B and E) and HF+DHA 712 
diet (C and F). The density of [3H]-CP-55,940 binding was significantly increased in the 713 
hippocampus and hypothalamic arcuate nucleus by HF diet, whereas the DHA supplement 714 
prevented the increase of [3
 717 
H]-CP-55,940 binding by HF diet. LF, low-fat diet; HF, high-715 
saturated fat diet; DHA, n-3 polyunsaturated docosahexaenoic acid. 716 
Fig 8. Autoradiograph depicting [3H]-Muscimol binding in the hippocampus of rats on LF 718 
(A), HF (B) and HF+DHA diet (C). The density of [3H]-Muscimol binding was significantly 719 
increased in the hippocampus by HF diet, whereas the DHA supplement prevented the 720 
increase of [3
 723 
H]-Muscimol binding by HF diet. LF, low-fat diet; HF, high-saturated fat diet; 721 




Fig 9. There was significant correlation between [3H]-CP55940 and [3
 727 
H]-Muscimol binding 725 





Table 1. Specific [3
  
H]-WAY-100635 binding (nCi/mg tissue; mean ± SEM) in different brain regions following 4 weeks of dietary 
intervention 
Mean ± SEM.    One-way ANOVA     P value, Tukey’s HSD post hoc    
   LF (n=5) HF (n=5)  HF+DHA (n=5)   F (2, 12) P value   HF vs. LF HF vs. DHA DHA vs. LF 




0.006 0.002 0.827 




0.007 0.022 0.790 




− − − 




− − − 




− − − 




− − − 
Pir 1.09±0.08 1.04±0.05 1.11±0.10   0.192 0.828   − − − 
Abbreviations: VMH, Ventromedial hypothalamus; Hip, Hippocampus; M1, primary motor cortex; ACC, anterior cingulate cortex; 
LSD, lateral septal nucleus; MeP, Medial posterodorsal amygdala; Pir, Piriform cortex; LF, low-fat diet; HF, high-fat diet; DHA, n-3 














Table 2. Specific [3
 
H]-Ketanserin binding (nCi/mg tissue; mean ± SEM) in different brain regions following 4 weeks of dietary intervention 
Mean ± SEM. 
 
 One-way ANOVA   
 
P value, Tukey’s HSD post hoc    
   LF (n=5) HF (n=5)  HF+DHA (n=5)   F (2, 12) P value   HF vs. LF HF vs. DHA DHA vs. LF 




0.003 0.002 0.99 




0.001 0.026 0.276 




0.026 0.015 0.943 




0.006 0.002 0.888 




− − − 




− − − 




− − − 




− − − 




− − − 
Abbreviations: MM, Medial mammillary nucleus; ACC, Anterior cingulated cortex; AA, Anterior amygdaloid area; CPu, Caudate putamen; 
Hip, hippocampus; M1, primary motor cortex; MeP, Medial posterodorsal amygdala; Pir, Piriform cortex; VMH, Ventromedial 










Table 3. Specific [3
  
H]-CP55940 binding (nCi/mg tissue; Mean±SEM) in different brain regions following 4 weeks of dietary intervention 
Mean±SEM   One-way ANOVA   P value, Tukey’s HSD post hoc    
 
LF HF HF+DHA 
 
F (2, 12) p- value 
 
HF vs. LF HF vs. DHA DHA vs. LF 
Hip 82.92±7.39  118.49±14.70  92.47±4.83    2.960 0.048   0.007 0.041 0.778 




<0.001 <0.001 0.999 




− − − 




0.045 0.013 0.764 




0.003 0.001 0.810 




0.020 0.005 0.651 




− − − 




− − − 




− − − 
ACC 57.30±6.91  60.84±6.21  55.27±3.41    0.244 0.787   − − − 
Abbreviations: Arc, hypothalamic arcuate nucleus; SN, Substantia nigra; VTA, Ventral tegmental area; Hip, hippocampus; VMH, 
Ventromedial hypothalamus; Amg, Amygdala; CPu, Caudate putamen; Pir, Piriform cortex; M1, Primary motor cortex; ACC, anterior 















Table 4. Specific [3
 
H]-Mmuscimol binding (nCi/mg tissue; mean ± SEM) in different brain regions following 4 weeks of dietary 
intervention 
Mean ± SEM. 
 
 One-way ANOVA   
 
P value, Tukey’s HSD post hoc    
 
 LF (n=5) HF (n=5)  DHA (n=5) 
 
F (2, 12) P value 
 
HF vs. LF HF vs. DHA DHA vs. LF 
Hip 3.43±0.47 5.25±0.57 3.05±0.67   4.386 0.040   0.021 0.038 0.656 




0.012 0.009 0.878 




0.020 0.011 0.760 
ACC 2.23±0.21 1.96±0.34 2.59±0.47   0.733 0.502   − − − 
Abbreviations: ACC, Anterior cingulated cortex; Hip, hippocampus; PCC, posterior cingulated cortex; LF, low-fat diet; HF, high-fat 




















































































































































































































































































































































































[3H] CP55940 binding density 
(nCi/mg tissue)
Fig 9.
